186 related articles for article (PubMed ID: 36613510)
1. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines.
Duarte D; Vale N
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769414
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
Duarte D; Cardoso A; Vale N
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
[TBL] [Abstract][Full Text] [Related]
4. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
5. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Abaza MS; Bahman AM; Al-Attiyah RJ
World J Gastroenterol; 2008 Sep; 14(33):5162-75. PubMed ID: 18777593
[TBL] [Abstract][Full Text] [Related]
6. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
Duarte D; Nunes M; Ricardo S; Vale N
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291699
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
8. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
9. An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells.
Shen X; Zhu HF; He FR; Xing W; Li L; Liu J; Yang J; Pan XF; Lei P; Wang ZH; Shen GX
Int Immunopharmacol; 2008 Dec; 8(13-14):1813-20. PubMed ID: 18817895
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
11. Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer.
Ma Y; Liu D; Wang D; Wang Y; Fu Q; Fallon JK; Yang X; He Z; Liu F
Mol Pharm; 2014 Aug; 11(8):2623-30. PubMed ID: 24712391
[TBL] [Abstract][Full Text] [Related]
12. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.
Smorenburg CH; Sparreboom A; Bontenbal M; Verweij J
Eur J Cancer; 2001 Dec; 37(18):2310-23. PubMed ID: 11720823
[TBL] [Abstract][Full Text] [Related]
14. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.
Choi MS; Kim SH; Kuh HJ
Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235
[TBL] [Abstract][Full Text] [Related]
15. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
[TBL] [Abstract][Full Text] [Related]
16. Hybrid peptides as platform for synchronized combination therapy.
Ashrafichoobdar E; Perez T; Ayalew L; Gorbanwand V; Monroy J; Slowinska K
Colloids Surf B Biointerfaces; 2023 Jun; 226():113326. PubMed ID: 37116378
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
Alsherbiny MA; Bhuyan DJ; Low MN; Chang D; Li CG
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576262
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
[TBL] [Abstract][Full Text] [Related]
19. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
[TBL] [Abstract][Full Text] [Related]
20. Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines.
Duarte D; Falcão SI; El Mehdi I; Vilas-Boas M; Vale N
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
